Cidara Therapeutics

Cidara Therapeutics

Cidara Therapeutics

Cidara is focused on developing novel anti-infectives to address serious infections.
Founded
2013
Raised
$100.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$6,900,000
Grant - 2017
CARB-X
$20,000,000
Post-IPO debt - 2016
Square 1 Bank
Team Size
10+
Employees
$6,900,000 Grant
biospace , businesswire

Cidara Awarded 6 9 Million Grant From CARB X To Advance Development Of Its First Cloudbreak Antibiotic Immunotherapy

$20,000,000 Post-IPO debt
FinSMEs

Cidara Therapeutics Receives $20M Credit Facility from Square 1 Bank